DTaP/IPV 2024
Contracts for the supply of combined diphtheria, tetanus and pertussis vaccines, with and without additional poliomyelitis antigen content
Buyer
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
Value
£127,180,800
Published
7 Jul 2023
Closes
16 Feb 2023
Procurement details
Source
Find a Tender
Region
Tower Hamlets
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33651600
Vaccines
Lots
Lot 1 Lot 1 - DTaP/IPV for the pre-school booster
Value not provided
Diphtheria, tetanus, pertussis and poliomyelitis (DTaP/IPV) vaccine indicated for boosting against diphtheria, tetanus, pertussis and poliomyelitis, and indicated for administration to individuals from 3 years of age. See ITO documents 2 and 4.<br/>Deliveries will be required over a period of 2 years, with the option to extend for up to an additional 24 mont...
Delivery: United Kingdom
Lot 2 Lot 2 - dTaP for the maternal pertussis immunisation programme
Value not provided
Diphtheria, tetanus, pertussis (dTaP) vaccine indicated for passive protection against pertussis in early infancy following maternal immunisation during pregnancy. See ITO documents 2 and 4.<br/>Deliveries will be required over a period of 2 years, with the option to extend for up to an additional 24 months.
Delivery: United Kingdom
Lot Lot 1 Lot 1 - DTaP/IPV for the pre-school booster
Value not provided
Contract for the provision of combined diphtheria, tetanus, and pertussis vaccine, with additional poliomyelitis antigen content. Additional information: Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the...
Delivery: United Kingdom
Lot Lot 2 Lot 2 - dTaP for the maternal pertussis immunisation programme
Value not provided
Contract for the provision of combined diphtheria, tetanus, and pertussis vaccine, without additional poliomyelitis antigen content. Additional information: Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of...
Delivery: United Kingdom
Documents
No document metadata is available for this public record.
Contains public sector information licensed under the Open Government Licence v3.0.